<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37583695</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Ferroptosis of CD163<sup>+</sup> tissue-infiltrating macrophages and CD10<sup>+</sup> PC<sup>+</sup> epithelial cells in lupus nephritis.</ArticleTitle><Pagination><StartPage>1171318</StartPage><MedlinePgn>1171318</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1171318</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1171318</ELocationID><Abstract><AbstractText Label="BACKGROUND">Dysregulation of cell death and defective clearance of dying cells are closely related to the pathogenesis of lupus nephritis (LN). However, the contribution of a recently discovered form of programmed cell death (PCD) called ferroptosis to LN has not been explored in detail. The purpose of this study was to investigate the role of ferroptosis and its associated metabolic pathways in the pathogenesis of LN.</AbstractText><AbstractText Label="METHODS">The composite gene expression scores were calculated by averaging the z-scored transformed log2 expressed genes within each form of PCD and pathway. Immunohistochemistry and immunofluorescence assays were used to verify the bioinformatics results.</AbstractText><AbstractText Label="RESULTS">We determined that ferroptosis is prominently and specifically elevated in the glomerular compartment of LN patients compared to other forms of PCD and kidney disease. This finding was then verified by immunohistochemical staining of 4-HNE (a key indicator for ferroptosis) expression in our own cohort (P &lt; 0.0001). Intercorrelation networks were observed between 4-HNE and blood urea nitrogen, SLE disease activity index, serum creatinine, and complement 4, and negatively correlated with glomerular filtration rate in our own LN cohort (P &lt; 0.05). Furthermore, enhanced iron metabolism and reduced fatty acid synthesis may be the most important factors for ferroptosis within the glomerulus. Through analysis of a single cell sequencing dataset and verification of immunohistochemical and immunofluorescence staining, aberrantly activated lipid peroxidation in CD163+ macrophages and CD10+ PC+ (pyruvate carboxylase) epithelial cells indicated that they may be undergoing ferroptosis in the glomerular compartment.</AbstractText><AbstractText Label="CONCLUSIONS">Two dysregulated genes, CD163 and PC, were identified and verified that were significantly associated with lipid peroxidation. Targeting ferroptosis in CD163+ macrophages and CD10+ PC+ epithelial cells may provide novel therapeutic approaches in LN.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Cheng, Mou, Su, Chen, Zhang, Xie, Xue, Lee, Wu and Du.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mou</LastName><ForeName>Lijun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Wenjing</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pathology, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yifan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Pui Y</ForeName><Initials>PY</Initials><AffiliationInfo><Affiliation>Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Huaxiang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AR070253</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C085464">CD163 antigen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079403" MajorTopicYN="Y">Ferroptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD163</Keyword><Keyword MajorTopicYN="N">PC</Keyword><Keyword MajorTopicYN="N">ferroptosis</Keyword><Keyword MajorTopicYN="N">lupus nephritis</Keyword><Keyword MajorTopicYN="N">programmed cell death</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>3</Hour><Minute>51</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37583695</ArticleId><ArticleId IdType="pmc">PMC10423811</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1171318</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anders HJ, Saxena R, Zhao MH, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Primers (2020) 6(1):7. doi: 10.1038/s41572-019-0141-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-019-0141-9</ArticleId><ArticleId IdType="pubmed">31974366</ArticleId></ArticleIdList></Reference><Reference><Citation>Mistry P, Kaplan MJ. Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis. Clin Immunol (Orlando Fla). (2017) 185:59&#x2013;73. doi: 10.1016/j.clim.2016.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.08.010</ArticleId><ArticleId IdType="pmc">PMC5299061</ArticleId><ArticleId IdType="pubmed">27519955</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko K, Wang J, Perper S, Jiang Y, Yanez D, Kaverina N, et al. . Bcl-2 as a therapeutic target in human tubulointerstitial inflammation. Arthritis Rheumatol (2016) 68(11):2740&#x2013;51. doi: 10.1002/art.39744</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39744</ArticleId><ArticleId IdType="pmc">PMC5083145</ArticleId><ArticleId IdType="pubmed">27159593</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. . Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell (2012) 149(5):1060&#x2013;72. doi: 10.1016/j.cell.2012.03.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.03.042</ArticleId><ArticleId IdType="pmc">PMC3367386</ArticleId><ArticleId IdType="pubmed">22632970</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Feng Z, Chen L, Li Y, Bian H, Geng J, et al. . TNF antagonist sensitizes synovial fibroblasts to ferroptotic cell death in collagen-induced arthritis mouse models. Nat Commun (2022) 13(1):676. doi: 10.1038/s41467-021-27948-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27948-4</ArticleId><ArticleId IdType="pmc">PMC8813949</ArticleId><ArticleId IdType="pubmed">35115492</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Q, Chen M, Liu M, Chen X, Zhu L, Xu J, et al. . Semaphorin 5A suppresses ferroptosis through activation of PI3K-AKT-mTOR signaling in rheumatoid arthritis. Cell Death disease (2022) 13(7):608. doi: 10.1038/s41419-022-05065-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-05065-4</ArticleId><ArticleId IdType="pmc">PMC9283415</ArticleId><ArticleId IdType="pubmed">35835748</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Jiang M, Li K, Li H, Zhou Y, Xiao X, et al. . Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity. Nat Immunol (2021) 22(9):1107&#x2013;17. doi: 10.1038/s41590-021-00993-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00993-3</ArticleId><ArticleId IdType="pmc">PMC8609402</ArticleId><ArticleId IdType="pubmed">34385713</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Hou S, Huang S, Li H, Li Y. Ferroptosis inhibitor regulates the disease progression of systematic lupus erythematosus mice model through Th1/Th2 ratio. Curr Mol Med (2022). doi: 10.2174/1566524022666220525144630</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566524022666220525144630</ArticleId><ArticleId IdType="pubmed">35619279</ArticleId></ArticleIdList></Reference><Reference><Citation>Grayson PC, Eddy S, Taroni JN, Lightfoot YL, Mariani L, Parikh H, et al. . Metabolic pathways and immunometabolism in rare kidney diseases. Ann Rheum Dis (2018) 77(8):1226&#x2013;33. doi: 10.1136/annrheumdis-2017-212935</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2017-212935</ArticleId><ArticleId IdType="pmc">PMC6045442</ArticleId><ArticleId IdType="pubmed">29724730</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumatol (1997) 40(9):1725&#x2013;. doi: 10.1002/art.1780400928</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai AM, Alarc&#xf3;n GS, Gordon C, Merrill JT, Fortin PR, et al. . Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheumatol (2012) 64(8):2677&#x2013;86. doi: 10.1002/art.34473</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. . The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int (2004) 65(2):521&#x2013;30. doi: 10.1111/j.1523-1755.2004.00443.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2004.00443.x</ArticleId><ArticleId IdType="pubmed">14717922</ArticleId></ArticleIdList></Reference><Reference><Citation>Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res (2003) 31(4):e15. doi: 10.1093/nar/gng015</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gng015</ArticleId><ArticleId IdType="pmc">PMC150247</ArticleId><ArticleId IdType="pubmed">12582260</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc Ser B-Stat Methodol (1995) 57(1):289&#x2013;300. doi: 10.1111/j.2517-6161.1995.tb02031.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1995.tb02031.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat (2001) 29(4):1165&#x2013;88. doi: 10.1214/aos/1013699998</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/aos/1013699998</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Y, Dai Q, Qi H. A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer. Cell Death discovery (2021) 7(1):71. doi: 10.1038/s41420-021-00451-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00451-x</ArticleId><ArticleId IdType="pmc">PMC8026591</ArticleId><ArticleId IdType="pubmed">33828074</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperandio S, Poksay K, de Belle I, Lafuente MJ, Liu B, Nasir J, et al. . Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix. Cell Death Differentiation (2004) 11(10):1066&#x2013;75. doi: 10.1038/sj.cdd.4401465</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cdd.4401465</ArticleId><ArticleId IdType="pubmed">15195070</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai X, Wang D, Zhang J. Programmed cell death, redox imbalance, and cancer therapeutics. Apoptosis an Int J programmed Cell Death (2021) 26(7-8):385&#x2013;414. doi: 10.1007/s10495-021-01682-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-021-01682-0</ArticleId><ArticleId IdType="pubmed">34236569</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. . Copper induces cell death by targeting lipoylated TCA cycle proteins. Science (2022) 375(6586):1254&#x2013;61. doi: 10.1126/science.abf0529</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf0529</ArticleId><ArticleId IdType="pmc">PMC9273333</ArticleId><ArticleId IdType="pubmed">35298263</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Hu C, Du Y, Tang X, Shao C, Xu T, et al. . Identification of iron metabolism-related gene signatures for predicting the prognosis of patients with sarcomas. Front Oncol (2020) 10:599816. doi: 10.3389/fonc.2020.599816</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2020.599816</ArticleId><ArticleId IdType="pmc">PMC7817539</ArticleId><ArticleId IdType="pubmed">33489900</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guig&#xf3; R, et al. . Characterization of mammalian selenoproteomes. Science (2003) 300(5624):1439&#x2013;43. doi: 10.1126/science.1083516</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1083516</ArticleId><ArticleId IdType="pubmed">12775843</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res (2021) 31(2):107&#x2013;25. doi: 10.1038/s41422-020-00441-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-00441-1</ArticleId><ArticleId IdType="pmc">PMC8026611</ArticleId><ArticleId IdType="pubmed">33268902</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Lin Z, Feng J, Liang Q, Zhao J, Zhang G, et al. . Identification of ferroptosis-related molecular markers in glomeruli and tubulointerstitium of lupus nephritis. Lupus (2022) 31(8):985&#x2013;97. doi: 10.1177/09612033221102076</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033221102076</ArticleId><ArticleId IdType="pubmed">35588147</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu W, Chen X. Identification of hub ferroptosis-related genes and immune infiltration in lupus nephritis using bioinformatics. Sci Rep (2022) 12(1):18826. doi: 10.1038/s41598-022-23730-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-23730-8</ArticleId><ArticleId IdType="pmc">PMC9637192</ArticleId><ArticleId IdType="pubmed">36335193</ArticleId></ArticleIdList></Reference><Reference><Citation>Alli AA, Desai D, Elshika A, Conrad M, Proneth B, Clapp W, et al. . Kidney tubular epithelial cell ferroptosis links glomerular injury to tubulointerstitial pathology in lupus nephritis. Clin Immunol (Orlando Fla). (2023) 248:109213. doi: 10.1016/j.clim.2022.109213</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2022.109213</ArticleId><ArticleId IdType="pubmed">36566913</ArticleId></ArticleIdList></Reference><Reference><Citation>Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, et al. . The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol (2019) 20(7):902&#x2013;14. doi: 10.1038/s41590-019-0398-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-019-0398-x</ArticleId><ArticleId IdType="pmc">PMC6726437</ArticleId><ArticleId IdType="pubmed">31209404</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Li H, Vanarsa K, Gidley G, Mok CC, Petri M, et al. . Association of urine sCD163 with proliferative lupus nephritis, fibrinoid necrosis, cellular crescents and intrarenal M2 macrophages. Front Immunol (2020) 11:671. doi: 10.3389/fimmu.2020.00671</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00671</ArticleId><ArticleId IdType="pmc">PMC7174755</ArticleId><ArticleId IdType="pubmed">32351512</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu A, van Rooyen L, Evans L, Armstrong N, Avizonis D, Kin T, et al. . Glucose metabolism and pyruvate carboxylase enhance glutathione synthesis and restrict oxidative stress in pancreatic islets. Cell Rep (2021) 37(8):110037. doi: 10.1016/j.celrep.2021.110037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110037</ArticleId><ArticleId IdType="pmc">PMC8720303</ArticleId><ArticleId IdType="pubmed">34818536</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappel DA, Deja S, Duarte JAG, Kucejova B, I&#xf1;igo M, Fletcher JA, et al. . Pyruvate-Carboxylase-mediated anaplerosis promotes antioxidant capacity by sustaining TCA cycle and redox metabolism in liver. Cell Metab (2019) 29(6):1291&#x2013;305.e8. doi: 10.1016/j.cmet.2019.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2019.03.014</ArticleId><ArticleId IdType="pmc">PMC6585968</ArticleId><ArticleId IdType="pubmed">31006591</ArticleId></ArticleIdList></Reference><Reference><Citation>von M&#xe4;ssenhausen A, Zamora Gonzalez N, Maremonti F, Belavgeni A, Tonnus W, Meyer C, et al. . Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion. Sci Adv (2022) 8(5):eabl8920.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8809683</ArticleId><ArticleId IdType="pubmed">35108055</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>